Description: Join 120+ Experts in Boston to Explore Combination Therapy in Obesity & NASH &Holistic Approaches to Metabolic Syndrome
Thank you to our speakers, sponsors, and delegates who joined us in Boston for the summit! If you are interested in the 2023 event, please get in touch at [email protected]
There has been a rise and fall of investment in NASH in the wake of highly demanding biopsy endpoints and late-stage clinical setbacks . However, a surge of interest in approaching metabolic syndrome more holistically, pivotal readouts in GLP-1 receptor agonists for the treatment of obesity, and trailblazing approaches to innovative trial design have resurrected and transformed the landscape for drug development in obesity, NASH, and other metabolic disorders.
Uniting industry experts dedicated to accelerating the frontier of therapeutic development in metabolic syndrome, the 6 th Obesity & NASH Drug Development Summit (previously the NASH Summit) , is the definitive industry forum sharing cross-industry insight to drive holistic approaches to drug development in metabolic syndrome.